HC Wainwright & Co. Reiterates Buy on VYNE Therapeutics – 1-for-18 Reverse Stock Split
HC Wainwright & Co. analyst Joseph Pantginis reiterates VYNE Therapeutics (NASDAQ:VYNE) with a Buy, 1-for-18 reverse stock split.
RBC Capital Reiterates Sector Perform on BioCryst Pharma, Maintains $10 Price Target
RBC Capital analyst Brian Abrahams reiterates BioCryst Pharma (NASDAQ:BCRX) with a Sector Perform and maintains $10 price target.
JMP Securities Reiterates Market Outperform on Vacasa, Maintains $3 Price Target
JMP Securities analyst Eric Ross reiterates Vacasa (NASDAQ:VCSA) with a Market Outperform and maintains $3 price target.
JMP Securities Reiterates Market Outperform on Inspired Entertainment, Maintains $18 Price Target
JMP Securities analyst Jordan Bender reiterates Inspired Entertainment (NASDAQ:INSE) with a Market Outperform and maintains $18 price target.
JMP Securities Reiterates Market Outperform on Booking Holdings, Maintains $2750 Price Target
JMP Securities analyst Nicholas Jones reiterates Booking Holdings (NASDAQ:BKNG) with a Market Outperform and maintains $2750 price target.
HC Wainwright & Co. Reiterates Buy on Oncternal Therapeutics, Maintains $7 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and maintains $7 price target.
HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $15 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $15 price target.
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $50 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $50 price target.
HC Wainwright & Co. Reiterates Buy on TRX Gold, Maintains $1.1 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates TRX Gold (AMEX:TRX) with a Buy and maintains $1.1 price target.
Needham Reiterates Buy on Airbnb, Maintains $155 Price Target
Needham analyst Bernie McTernan reiterates Airbnb (NASDAQ:ABNB) with a Buy and maintains $155 price target.